Related references
Note: Only part of the references are listed.An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain
Cory Toth et al.
PAIN (2012)
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
Ethan B. Russo
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial
Mark A. Ware et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2010)
Cannabinoid-opioid interactions during neuropathic pain and analgesia
Ittai Bushlin et al.
CURRENT OPINION IN PHARMACOLOGY (2010)
Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial
Turo J. Nurmikko et al.
PAIN (2007)
Oromucosal Δ9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis:: An uncontrolled, open-label, 2-year extension trial
David J. Rog et al.
CLINICAL THERAPEUTICS (2007)
Risk factors for suicidality in Europe: Results from the ESEMED study
M. Bernal et al.
JOURNAL OF AFFECTIVE DISORDERS (2007)
Cannabis in painful HIV-associated sensory neuropathy - A randomized placebo-controlled trial
D. I. Abrams et al.
NEUROLOGY (2007)
EFNS guidelines on pharmacological treatment of neuropathic pain
N. Attal et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
Suicidality in chronic pain: a review of the prevalence, risk factors and psychological links
Nicole K. Y. Tang et al.
PSYCHOLOGICAL MEDICINE (2006)
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
DJ Rog et al.
NEUROLOGY (2005)
Core outcome measures for chronic pain clinical trials: IMMPACT recommendations
RH Dworkin et al.
PAIN (2005)
Pharmacologic management part 1: Better-studied neuropathic pain diseases
MM Backonja et al.
PAIN MEDICINE (2004)
Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial
KB Svendsen et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial
JS Berman et al.
PAIN (2004)
What should be the core outcomes in chronic pain clinical trials?
DC Turk et al.
ARTHRITIS RESEARCH & THERAPY (2004)
Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain - A randomized controlled trial
M Karst et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Axis I and axis II disorders as predictors of prospective suicide attempts: Findings from the collaborative longitudinal personality disorders study
S Yen et al.
JOURNAL OF ABNORMAL PSYCHOLOGY (2003)
Designing pain research from the patient's perspective: What trial end points are important to patients with chronic pain?
D Casarett et al.
PAIN MEDICINE (2001)
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale
JT Farrar et al.
PAIN (2001)
The clinical picture of neuropathic pain
TS Jensen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Share Paper
